%0 Journal Article
%A Perez, Paz
%A Franco, Virginia
%A Oliva, Manuel
%A Lopez Escamez, Jose A
%T A Pilot Study Using Intratympanic Methylprednisolone for Treatment of Persistent Posterior Canal Benign Paroxysmal Positional Vertigo.
%D 2019
%@ 1308-7649
%U http://hdl.handle.net/10668/10650
%X To assess the effect of intratympanic methylprednisolone (ITMP) in posterior canal benign paroxysmal positional vertigo (BPPV) that fails treatment involving repositioning maneuver in a case series. Nine patients with persistent posterior canal BPPV after 6 or more repositioning maneuvers were treated by ITMP (two weekly doses of 0.3-0.4 mL at 40 mg/mL) before repeating the repositioning procedures. Following ITMP treatment, 7 out of 9 patients were relieved of their symptoms and did not exhibit positional nystagmus after 1 or 2 repositioning maneuvers. The number of positional maneuvers performed before and after ITMP treatment in these 7 patients showed a statistically significant (p=0.016) reduction in the amount of repositioning treatments required. None of the 7 respondent patients showed any relapses during the follow-up period (follow-up range: 11-95 months). Administering ITMP before resuming repositioning procedures can be a useful treatment for persistent BPPV of the posterior canal.
%K Benign paroxysmal positional vertigo
%K intratympanic injection
%K methylprednisolone
%~